InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Fortress Biotech, Inc.

FBIO Clue Score35
United States Fiscal year ends December CIK 0001429260
$2.14 +2.15% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $2.14 −28.83% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue16.5Operating income−65.7Net income−55.1Fiscal year 2017Revenue17.2 +4.6%Operating income−89.8Net income−66.9Fiscal year 2018Revenue26.9 +55.9%Operating income−120.0Net income−84.1Fiscal year 2019Revenue36.6 +36.3%Operating income−110.8Net income−40.0Fiscal year 2020Revenue45.6 +24.5%Operating income−94.3Net income−46.5Fiscal year 2021Revenue68.8 +50.9%Operating income−188.5Net income−64.7EPS, diluted−0.79Fiscal year 2022Revenue75.7 +10.1%Operating income−203.6Net income−86.6EPS, diluted−15.97Fiscal year 2023Revenue84.5 +11.6%Operating income−142.3Net income−60.6EPS, diluted−8.47Fiscal year 2024Revenue57.7 −31.8%Operating income−110.4Net income−46.0EPS, diluted−2.69Fiscal year 2025Revenue63.3 +9.7%Operating income−70.2Net income6.8EPS, diluted−0.07
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 16.5 17.2 26.9 36.6 45.6 68.8 75.7 84.5 57.7 63.3
Growth +4.6% +55.9% +36.3% +24.5% +50.9% +10.1% +11.6% −31.8% +9.7%
Operating income −65.7 −89.8 −120.0 −110.8 −94.3 −188.5 −203.6 −142.3 −110.4 −70.2
Net income −55.1 −66.9 −84.1 −40.0 −46.5 −64.7 −86.6 −60.6 −46.0 6.8
Growth
EPS, diluted n/a n/a n/a n/a n/a −0.79 −15.97 −8.47 −2.69 −0.07

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin−398.7%Net margin−334.3%Free cash flow margin−316.6%Fiscal year 2017Operating margin−520.7%Net margin−387.8%Free cash flow margin−475.2%Fiscal year 2018Operating margin−446.4%Net margin−313.0%Free cash flow margin−394.1%Fiscal year 2019Operating margin−302.5%Net margin−109.1%Free cash flow margin−265.7%Fiscal year 2020Operating margin−206.7%Net margin−102.0%Free cash flow margin−187.7%Fiscal year 2021Operating margin−274.1%Net margin−94.1%Free cash flow margin−176.0%Fiscal year 2022Operating margin−268.8%Net margin−114.3%Free cash flow margin−240.4%Fiscal year 2023Operating margin−168.4%Net margin−71.7%Free cash flow margin−151.8%Fiscal year 2024Operating margin−191.4%Net margin−79.8%Free cash flow margin−139.0%Fiscal year 2025Operating margin−111.0%Net margin10.8%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −398.7% −520.7% −446.4% −302.5% −206.7% −274.1% −268.8% −168.4% −191.4% −111.0%
Net margin −334.3% −387.8% −313.0% −109.1% −102.0% −94.1% −114.3% −71.7% −79.8% 10.8%
Free cash flow margin −316.6% −475.2% −394.1% −265.7% −187.7% −176.0% −240.4% −151.8% −139.0% n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−45.8Capital expenditure−6.4Free cash flow−52.2Fiscal year 2017Operating cash flow−81.3Capital expenditure−0.6Free cash flow−82.0Fiscal year 2018Operating cash flow−98.8Capital expenditure−7.1Free cash flow−105.9Fiscal year 2019Operating cash flow−95.0Capital expenditure−2.3Free cash flow−97.3Buybacks0.0Dividends paid0.0Fiscal year 2020Operating cash flow−83.7Capital expenditure−1.9Free cash flow−85.6Buybacks−0.1Dividends paid−0.2Fiscal year 2021Operating cash flow−116.5Capital expenditure−4.6Free cash flow−121.1Dividends paid−0.7Fiscal year 2022Operating cash flow−179.4Capital expenditure−2.7Free cash flow−182.1Dividends paid−0.7Fiscal year 2023Operating cash flow−128.2Capital expenditure−0.1Free cash flow−128.3Dividends paid−0.7Fiscal year 2024Operating cash flow−80.2Capital expenditure0.0Free cash flow−80.2Dividends paid−0.7Fiscal year 2025Operating cash flow−65.8Dividends paid−0.7
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −45.8 −81.3 −98.8 −95.0 −83.7 −116.5 −179.4 −128.2 −80.2 −65.8
Capital expenditure −6.4 −0.6 −7.1 −2.3 −1.9 −4.6 −2.7 −0.1 0.0 n/a
Free cash flow −52.2 −82.0 −105.9 −97.3 −85.6 −121.1 −182.1 −128.3 −80.2 n/a
Growth
Buybacks n/a n/a n/a 0.0 −0.1 n/a n/a n/a n/a n/a
Dividends paid n/a n/a n/a 0.0 −0.2 −0.7 −0.7 −0.7 −0.7 −0.7

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash88.3Total debt30.2Net cash (debt)58.1Shareholders’ equity38.5Debt to equity0.79Fiscal year 2017Cash95.0Total debt67.5Net cash (debt)27.4Shareholders’ equity52.6Debt to equity1.28Fiscal year 2018Cash65.5Total debt84.4Net cash (debt)−18.9Shareholders’ equity1.9Debt to equity45.58Fiscal year 2019Cash136.9Total debt84.7Net cash (debt)52.2Shareholders’ equity26.2Debt to equity3.23Fiscal year 2020Cash233.4Total debt51.7Net cash (debt)181.7Shareholders’ equity100.3Debt to equity0.52Fiscal year 2021Cash305.7Total debt42.9Net cash (debt)262.8Shareholders’ equity108.7Debt to equity0.40Fiscal year 2022Cash178.3Total debt91.7Net cash (debt)86.5Shareholders’ equity41.7Debt to equity2.20Fiscal year 2023Cash80.9Total debt60.9Net cash (debt)20.1Shareholders’ equity22.5Debt to equity2.70Fiscal year 2024Cash57.3Total debt58.0Net cash (debt)−0.7Shareholders’ equity22.7Debt to equity2.55Fiscal year 2025Cash79.4Total debt52.4Net cash (debt)27.0Shareholders’ equity49.9Debt to equity1.05
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 88.3 95.0 65.5 136.9 233.4 305.7 178.3 80.9 57.3 79.4
Total debt 30.2 67.5 84.4 84.7 51.7 42.9 91.7 60.9 58.0 52.4
Net cash (debt) 58.1 27.4 −18.9 52.2 181.7 262.8 86.5 20.1 −0.7 27.0
Shareholders’ equity 38.5 52.6 1.9 26.2 100.3 108.7 41.7 22.5 22.7 49.9
Debt to equity 0.79 1.28 45.58 3.23 0.52 0.40 2.20 2.70 2.55 1.05

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022† 31 Dec 2022 FY2023 31 Dec 2023 FY2024† 31 Dec 2024 FY2025 31 Dec 2025
Operations
−45.8 −81.3 −98.8 −95.0 −83.7 −116.5 −179.4 −128.2 −80.2 −65.8
Growth
0.9 1.2 n/a n/a n/a n/a n/a n/a n/a n/a
Investment
−6.4 −0.6 −7.1 −2.3 −1.9 −4.6 −2.7 −0.1 0.0 n/a
calc −52.2 −82.0 −105.9 −97.3 −85.6 −121.1 −182.1 −128.3 −80.2 n/a
Growth
calc n/a n/a n/a n/a n/a −1.48 −30.74 −15.82 −3.86 n/a
−6.1 −40.2 18.8 20.1 −7.2 40.5 −22.9 −2.1 −15.0 10.1
Financing
42.9 150.4 50.6 146.7 172.4 149.0 75.3 32.7 70.6 77.4
n/a n/a n/a 0.0 −0.2 −0.7 −0.7 −0.7 −0.7 −0.7
n/a n/a n/a 0.0 −0.1 n/a n/a n/a n/a n/a

† The diluted share count jumps at 2022 and 2024, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.